A new study labeled HPTN 035 has shown that a new vaginal gel designed to help prevent HIV infection in females is demonstrating some promising signs in a trial study done in both the United States and Africa. The study was funded by the NIAID (National Institute of Allergy and Infectious Diseases) and presented this [...]

[Read more →]